In this task, you need to Translate Czech text to English.

Q: P°edm tem °e en  je kosmetick² v²robek pro odstra ov n  keratotick²ch z tek na poko ce, kter² je tvo°en prou kem, ulo en²m do s  ku s 2 a  12 % hmotnostn mi kapaliny, vzta eno na hmotnost prou ku. Prou ek sest v  z ohebn ho substr tu, na n j  je nanesen prost°edek s obsahem adhezivn ho polymeru, kter² je za sucha nelepiv², av ak po namo en  se st v  lepiv²m a mobiln m. Prost°edek se po zvlh en  p°ilo   na   st obli eje, kter  m  b²t o et°ena a po uschnut  se sejme spolu s keratotick²mi z tkami.\

A: The object is a cosmetic product for removing keratotic substances on the skin, which is formed by flow, deposited with 2 and 12% by weight of liquid, based on the weight of the stream. A thin, stretchy substratum on which the adhesive-free adhesive is applied, which is non-adhesive when dry, and when used in adhesive and mobile, the agent is wetted. it was on the face, which was removed and after drying it was removed together with keratotics. \ t
****
Q: R m kloubov ho podvozku obsahuje prav² postrann  nosn k (2A), lev² postrann  nosn k (2B), p°edn  nosn k  (3A), zadn  nosn k (3B) a kloubov  prost°edky (4A, 4B), p°i em  r m je vytvo°en ze dvou polor m  (1A, 1B), z nich  ka d² je vytvo°en v podstat  ve tvaru p smene L. Ka d² polor m (1A, 1B) nese trak n  motor (5A, 5B), p°evodov  soukol  (6A, 6B), diferenci l (7A, 7B) a n pravu (8A, 8B), p°i em  p°evodov  soukol  (6A, 6B), diferenci ly (7A, 7B) a n pravy (8A, 8B) jsou integrov ny ve sv²ch p° slu n²ch polor mech (1A, 1B).\

A: The chassis chassis includes a right-hand side carrier (2A), a left-hand side carrier (2B), a front carrier (3A), a rear carrier (3B), and a hinge (4A, 4B). i em rm is made up of two poles m (1A, 1B), of which c is formed essentially in the form of the p direction L. Ka d or polor m (1A, 1B) carries the traction motor (5A, 5B ), gear conversion (6A, 6B), differential l (7A, 7B) and right (8A, 8B), the conversion of the gear (6A, 6B), the differential λ (7A, 7B) and the right (8A, 8B) are integrated in their respective fields (1A, 1B). \ T
****
Q: Popisuje se pou it  agonisty amylinu pro p° pravu farmaceutick ho prost°edku k l  en  non-inzulin-dependentn ho diabetick ho jedince typu II a ke sni ov n  hladiny gluk zy v krvi u tohoto jedince.\

A:
In the present invention there is described the use of amylin agonist for preparing a pharmaceutical preparation intended for treating non-insulin-dependent diabetic individual of the type II and for reducing glucose level in blood of this individual.
****